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Introduction {#sec001}
============

Cytokines produced by a variety of immune cells play an important role in gene activation, as well as growth and differentiation of immune cells in both innate and adaptive immune responses. Cytokines influence the local activation of immune cells, and play a critical role in the regulation of immune and inflammatory responses \[[@pone.0118008.ref001]--[@pone.0118008.ref003]\]. The cytokine profiles produced by T-helper type 1 (Th1), Th2, Th17, and Treg lymphocytes show distinct patterns. Cytokines produced by TH1 cells include interleukin-2 (IL-2), interferon gamma (IFN-γ) and tumor necrosis factor (TNF), and constitute a pro-inflammatory cytokine profile. On the other hand, cytokines produced by Th2 cells, including IL-4, IL-5 and IL-10, exhibit a predominantly anti-inflammatory cytokine profile \[[@pone.0118008.ref004]\]. Furthermore, Th17 cells, which produce IL-17, are crucial for defending against fungi and extracellular bacteria. The Th17 cells were shown to play a crucial role in the induction of autoimmune diseases and allergen-specific response \[[@pone.0118008.ref005]\]. In addition to these effector subsets, the CD4+ Treg, characterized by the forkhead box P3 (Foxp3) protein, suppresses adaptive T-cell responses and prevents autoimmunity \[[@pone.0118008.ref006]\]. Complex networks of cytokines are involved in dynamic and homeostatic regulation of immune responses and other biological pathways \[[@pone.0118008.ref007]\].

Several mechanisms contribute to the functionality of single nucleotide polymorphisms (SNPs) in cytokine genes, including amino acid changes (IL-6R, IL-13 and IL-1α), exon skipping (IL-7Rα), proximal promoter variants (IL-1β, IL-RA, IL-2, IL-6, IL-10, IL-12, IL-13, IL-16, TNF, IFN-γ, and transforming growth factor-beta (TGF-β)), distal promoter variants (IL-6 and IL-18) and intronic enhancer variants (IL-8) \[[@pone.0118008.ref008]\]. Investigation into the associations between cytokine genotypes and susceptibility and prognosis of diseases has implications in disease etiology and potential therapeutic intervention \[[@pone.0118008.ref009],[@pone.0118008.ref010]\]. Genotyping technologies include both solid phase of gels and glass slide arrays, as well as homogeneous solution assay formats of mass spectrometry and capillary electrophoresis \[[@pone.0118008.ref011]\]. Traditionally, genotyping for cytokine SNPs has been conducted using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) (IL-1β -511, IL-1β +3954, IL-2--330, IL-6--174, IL-10--819 and IL-10--592) \[[@pone.0118008.ref012]\], PCR-SSCP (IL-4 promoter-590, IL-4 receptor α and IL-10--1082) \[[@pone.0118008.ref013]\] and PCR-SSP (IL-6--174, IL-10--1082, -819 and-592) \[[@pone.0118008.ref014],[@pone.0118008.ref015]\]. Furthermore, multiplexing methodologies have the advantage of simultaneous detection of multiple nucleic acid sequences in a single reaction, which reduces the time, labor, and costs that are required, as compared to single-reaction-based detection methods \[[@pone.0118008.ref011]\]. As a high-throughput technique, pyrosequencing (IL-1β −31, IL-6 −174, −572, −597, IL-10 and IL-12β 3′+1158) \[[@pone.0118008.ref016]\] and microarrays (IL-6 −596, −572, −174, TNF-α −308, −238, IL-1β −511 and −31) \[[@pone.0118008.ref017]\] have been developed.

Microsphere-based suspension array has been used as a platform for high-throughput nucleic acid detection in various fields \[[@pone.0118008.ref011],[@pone.0118008.ref018]--[@pone.0118008.ref024]\]. Advantages of the suspension array technology include fast data acquisition, excellent sensitivity and specificity, and capacity for multiplexed analysis \[[@pone.0118008.ref011]\].

The present study demonstrated the improvement of allele specific extension primers by several modification strategies and validated a high-throughput genotyping assay using a combine platform of multiplex PCR and Luminex xTAG to examine several cytokine SNPs. Such assay systems could be implemented in small pilot studies or large-scale population studies to investigate the association between multiple cytokine SNPs and immune-related diseases.

Materials and Methods {#sec002}
=====================

1. DNA samples {#sec003}
--------------

A total of 152 healthy Korean subjects were included as controls in this study, comprising staff and students from the College of Medicine at the Catholic University of Korea. DNA was isolated from peripheral blood using the AccuPrep Genomic DNA Extraction kit (Bioneer Corporation, Daejeon, Korea), following the manufacturer's instructions. DNA concentration was adjusted to 100 ng/μl and used as PCR templates for genotyping.

2. Ethics statement {#sec004}
-------------------

This study was approved by the Institutional Review Board (IRB) of the Catholic University of Korea (IRB Number: MC13SISI0126). Written informed consent was obtained from all participates involved in this study.

3. Quality control panel for genotyping and primer design for multiplex PCR {#sec005}
---------------------------------------------------------------------------

We performed a study on 20 SNPs for 13 cytokine genes in which genotyping results from multiplex PCR were confirmed, with results from the quality control genotyping panel acquired from sequencing. SNP-specific primer for multiplex PCR was designed following the methodology described by Kaarel et al \[[@pone.0118008.ref025]\]. Each specific primer was designed based on an optimal melting temperature between 56°C and 60°C. The melting temperature was calculated using the the Oligo Calculator (<http://mbcf.dfci.harvard.edu/docs/oligocalc.html>). In addition, each specific primer was designed to cover one span between the forward and reverse primers. However, the span of the TGF-β1 specific primer was designed differently at 46 bp. First, the PCR primer was added to a universal sequence (5′-GATCAGGCGTCTGTCGTGCTC-3′) at the 5′ end of each specific primer ([Table 1](#pone.0118008.t001){ref-type="table"}).

10.1371/journal.pone.0118008.t001

###### List of primer sequences for multiplex PCR amplifications.

![](pone.0118008.t001){#pone.0118008.t001g}

  Group                   Gene               SNP Position   rs Number   Direction               Sequence (5′- 3′)                       Span(bp)[\*](#t001fn001){ref-type="table-fn"}   Tm   Length   Amplicon Size (bp)
  ----------------------- ------------------ -------------- ----------- ----------------------- --------------------------------------- ----------------------------------------------- ---- -------- --------------------
  **Proinflammatory**     IL-1α              -889           rs1800587   Forward                 GAGAAATTCTTTAATAATAGTAACCAGGCAACA       1                                               57   33       105
                                                                        Reverse                 CATGGATTTTTACATATGAGCCTTCAATG                                                           56   29       
                          IL-1β              +3962          rs1143634   Forward                 TGCTCCACATTTCAGAACCTATCTTCTT            1                                               57   28       96
                                                                        Reverse                 CATAAGCCTCGTTATCCCATGTGTC                                                               58   25       
                                             -511           rs16944     Forward                 TCCTGCAATTGACAGAGAGCTCC                 1                                               57   23       87
                                                                        Reverse                 TTGGGTGCTGTTCTCTGCCTC                                                                   56   21       
                          IL-1R              +1970          rs2234650   Forward                 AGGGGGAAAGCCCGAGGGAG                    1                                               60   20       84
                                                                        Reverse                 GGCGCAGTGGTCGAGTCTGCA                                                                   60   21       
                          IL-1RA             +11100         rs315952    Forward                 CGCCTTCATCCGCTCAGACAG                   1                                               58   21       85
                                                                        Reverse                 CTCAAAACTGGTGGTGGGGCC                                                                   58   21       
                          IL-6               -174           rs1800795   Forward                 ACTTTTCCCCCTAGTTGTGTCTTGC               1                                               58   25       94
                                                                        Reverse                 TTGTGCAATGTGACGTCCTTTAGCAT                                                              56   26       
  **Th1**                 IL-2               +166           rs2069763   Forward                 ACACAGCTACAACTGGAGCATTTACT              1                                               56   26       102
                                                                        Reverse                 ATTAATTCCATTCAAAATCATCTGTAAATCCAG                                                       56   33       
                                             -330           rs2069762   Forward                 CAATATGCTATTCACATGTTCAGTGTAGTTTTA       1                                               57   33       109
                                                                        Reverse                 GATACAAAAGTAACTCAGAAAATTTTCTTTGTC                                                       56   33       
                          IL-12              -1188          rs3212227   Forward                 TCACAATGATATCTTTGCTGTATTTGTATAGTT       1                                               56   33       104
                                                                        Reverse                 CTGATTGTTTCAATGAGCATTTAGCATC                                                            56   28       
                          IFN-γ              5644           rs2430561   Forward                 CACAATTGATTTTATTCTTACAACACAAAATCAAATC   1                                               57   37       106
                                                                        Reverse                 AGTGTGTGTGTGTGTGTGTGTGTGTG                                                              60   26       
                          TNF-α              -308           rs1800629   Forward                 GAGGCAATAGGTTTTGAGGGGCATG               1                                               59   25       88
                                                                        Reverse                 CTGGAGGCTGAACCCCGTCC                                                                    60   20       
                                             -238           rs361525    Forward                 CAGAAGACCCCCCTCGGAATC                   1                                               58   21       86
                                                                        Reverse                 ACACTCCCCATCCTCCCTGCTC                                                                  60   22       
  **Th2**                 IL-4               -1098          rs2243248   Forward                 AGGGCTGATTTGTAAGTTGGTAAGAC              1                                               56   26       96
                                                                        Reverse                 CCTCAGCTAATTAGGAAAAAGAGCTAC                                                             57   27       
                                             -590           rs2243250   Forward                 CAAAACACCTAAACTTGGGAGAACATTGT           1                                               57   29       93
                                                                        Reverse                 TCTCCTACCCCAGCACTGGGG                                                                   60   21       
                          IL-4Rα             1902           rs1801275   Forward                 GGCCCCCACCAGTGGCTATC                    1                                               60   20       85
                                                                        Reverse                 CTCCACCGCATGTACAAACTCC                                                                  57   22       
                          IL-10              -1082          rs1800896   Forward                 ACAACACTACTAAGGCTTCTTTGGGA              1                                               56   26       92
                                                                        Reverse                 CTCTTACCTATCCCTACTTCCCC                                                                 57   23       
                                             -819           rs1800871   Forward                 GTGTACCCTTGTACAGGTGATGTAA               1                                               56   25       92
                                                                        Reverse                 GTGAGCAAACTGAGGCACAGAGAT                                                                57   24       
                                             -592           rs1800872   Forward                 ACATCCTGTGACCCCGCCTGT                   1                                               58   21       88
                                                                        Reverse                 TTTCCAGAGACTGGCTTCCTACAG                                                                57   24       
  **Immune modulatory**   TGF-β1             codon 10       rs1800470   Forward                 CGGGCTGCGGCTGCTGC                       46                                              59   17       123
                          codon 25           rs1800471      Reverse     GATAGTCCCGCGGCCGGC                                              59                                              18            
                          Universal Primer                              GATCAGGCGTCTGTCGTGCTC                                           58                                              21            

\* span: The distance between a forward primer and reverse primer on target sequence.

IL: interleukin, IFN: interferon, TNF: tumor necrosis factor, TGF: transforming growth factor, R: receptor, RA: receptor antagonist

Universal primer: The universal sequences were not matched with any genomic DNA sequences. All the primers include a universal sequence at individual 5′-end.

4. Multiplex PCR {#sec006}
----------------

Genomic DNA (100 ng/μl in distilled water) was denatured at 98°C, and then cooled at 4°C prior to PCR. The first PCR included 100 ng of genomic DNA, 300 nM of each SNP specific primer, PCR buffer (50 mM Tris base pH 8.7, 20 mM ammonium sulfate, 2 mM MgCl~2~, 0.1 mg/ml BSA), 0.2 mM of each dNTP, distilled H~2~O and 1.25 U of Taq DNA polymerase (Genelabs, Seongnam, Korea) in a total volume of 15 μl. Amplification was performed in a GeneAmp PCR System 9700 thermocycler (Applied Biosystems, Foster City, CA, USA) using the following conditions: 1 cycle at 98°C for 45 s; 35 cycles of denaturation at 95°C for 20 s, annealing at 60°C for 2 min, extension at 72°C for 20 s. The duration between the annealing and extension steps in the GeneAmp PCR System 9700 thermocycler was set at a 3% ramp speed. The length of the amplified products was confirmed by electrophoresis on a 2% agarose gel.

The next PCR was carried out with the universal primer. The second PCR step included 5 μl of the first PCR product, 40 nM of the universal primer (5′-GATCAGGCGTCTGTCGTGCTC-3′), PCR buffer (75 mM Tis HCl (pH9.0), 50 mM KCl, 20 mM (NH~4~)~2~SO~4~, 2 mM MgCl~2~), 0.3 mM of each dNTP, distilled H~2~O and 5 U Taq DNA polymerase (Biotools B&M Labs, Madrid, Spain) in a total volume of 50 μl. Amplification was performed in a GeneAmp PCR System 9700 thermocycler (Applied Biosystems, Foster City, CA, USA) using the following conditions: 1 cycle at 95°C for 10 min; 35 cycles of denaturation at 95°C for 30 s, annealing at 54°C for 30 s, extension at 72°C for 5 s. Amplified product size was confirmed by electrophoresis on a 2% agarose gel.

5. Allele-specific primer extension (ASPE) {#sec007}
------------------------------------------

The products from the second PCR step were treated with shrimp alkaline phosphatase (SAP) to eliminate the activity of deoxynucleotides. The final volume of the phase enzyme treatment reaction was 20 μl, and contained 17 μl of the second PCR product, SAP reaction buffer (20 mM Tris-HCl (pH 8.0), 10 mM MgCl~2~) and 0.25 U SAP (both from USB, Ohio, USA). The reactions were incubated at 37°C for 30 min, and then inactivated by heating at 95°C for 10 min.

Multiplex allele-specific primer extension reactions were carried out in a total volume of 20 μl. The reaction components were 10 μl of enzyme-treated multiplex PCR products, 1 pM of each tag-allele specific extension primers, PCR buffer (75 mM Tis HCl (pH 9.0), 50 mM KCl, 20 mM (NH~4~)~2~SO~4~, 2 mM MgCl~2~), 400 μM biotin deoxycytidine triphosphate (Biotin-dCTP), 100 μM deoxyadnosine triphosphate (dATP), deoxyguanosine triphosphate (dGTP), deoxythymidine triphosphate (dTTP) mix, distilled H~2~O and 0.5 U Taq DNA polymerase (Biotools B&M Labs, Madrid, Spain). The reactions were carried out using a GeneAmp PCR System 9700 thermocycler (Applied Biosystems, Foster City, CA, USA) under the following conditions: 1 cycle at 95°C for 5 min; 5 cycles of denaturation at 95°C for 10 s; and annealing and extension at 60°C for 5 min.

6. Hybridization {#sec008}
----------------

For hybridization, 25 μl of 2X Tm hybridization buffer (0.4 M NaCl, 0.2 M Tris (pH 8.0),

0.16% Triton X-100) containing 2500 of each tag-coupled microsphere set was added to 20 μl of the ASPE reaction products and 5 μl distilled H~2~O to achieve a final volume of 50 μl. The mixtures were denatured by heating at 95°C for 90 s and then incubated at 37°C for 1 h. The hybridized microspheres were washed twice with 75 μl of 1X Tm hybridization buffer (0.2 M NaCl, 0.1 M Tris (pH 8.0), 0.08% Triton X-100) followed by centrifugation at 8000 g for 2 min. The supernatant was removed, and 75 μl of 1X Tm hybridization buffer containing 2 μg/mL streptavidin-R-phycoerythrin was added to the microsphere-hybridized ASPE reaction products. The reaction was incubated at 37°C for 15 min. Microsphere fluorescence was measured using a Luminex 200 analyzer (Luminex Corporation, Austin, TX, USA) at 37°C and analyzed with the associated software. The phycoerythrin (PE) median fluorescence intensities (MFI) were determined for each bead, and MFI ratios were calculated for bead pairs specific for the alternate alleles of each cytokine.

7. Data Analysis {#sec009}
----------------

The allele frequencies were determined using Microsoft Office Excel. Hardy-Weinberg equilibrium (HWE) in controls was analyzed for each SNP using SNPStats (<http://bioinfo.iconcologia.net/snpstats/start.htm>).

Results {#sec010}
=======

1. Two-step multiplex PCR for 20 SNPs of 13 cytokines {#sec011}
-----------------------------------------------------

To determine simultaneously the 20 SNPs of 13 cytokine genes in a single tube, the target genes were amplified by nested PCR. These cytokine SNPs have been studied during the Cytokine Component of the 13^th^ International Histocompatibility Workshop. These cytokine gens can be grouped into pro-inflammatory cytokines (IL-1, IL-1R and IL-6), Th1 cytokines (IL-2, IL-12, INF-γ and TNF-α), Th2 cytokines (IL-4, IL-4Rα and IL-10) and Immunemodulatory (TGF-β).

Nineteen pairs of primer were used for the first PCR reaction, and the nucleotide sequences of the universal primer used in the second PCR were designed in the absence of the genomic sequence. This two-step multiplex PCR was optimized for several parameters, including primer concentration, number of PCR cycles, and annealing temperature, as described in Materials and Methods. Optimal conditions yielded PCR products of equal sizes, as shown in [Fig. 1](#pone.0118008.g001){ref-type="fig"}. The first PCR primers and the universal primer were verified for the amplification of the target genes without cross-hybridization from the SNP genotyping results using fluorescence bead arrays.

![Agarose gel electrophoresis images of cytokine genes amplified by multiplex PCR.\
(A) The first polymerase chain reaction with 3% ramp speed was amplified by specific sequences, and the size of the amplified products were approximately 100 bp. (B) Products from the second polymerase chain reaction were amplified by the universal sequences and the size of the amplified products were approximately 100 bp as well. The DNA marker (M) is a commercial 100 bp ladder.](pone.0118008.g001){#pone.0118008.g001}

2. Quality control panel {#sec012}
------------------------

A total of 20 SNPs belonging to 13 cytokine genes were genotyped in 152 healthy Korean subjects by direct nucleotide sequencing, using the sequencing primers. To validate the performance characteristics of fluorescence bead array and determine the specificity of extension primers, 12 genomic DNA samples representing SNPs in Koreans subjects were selected as the quality control panel. SNP genotypes of 13 cytokines in 12 samples are shown in [Table 2](#pone.0118008.t002){ref-type="table"}. Among the 20 SNP regions, 12 regions showed two homozygote and heterozygote genotypes and 6 regions displayed one homozygote and heterozygote genotypes in Koreans. However, TGF-β1 (codon 25) and IL-6 (-174) regions showed homozygote genotype of only one allele. Therefore, the specificity of the 30 extension primers in 18 SNP regions could be extensively tested using this quality control panel.

10.1371/journal.pone.0118008.t002

###### List of quality control panel genotypes by sequencing.

![](pone.0118008.t002){#pone.0118008.t002g}

                Proinflammatory                       Th1                            Th2                            Immune modulatory        
  ------------- ----------------- ---- ---- ---- ---- ----- ---- ---- ---- ---- ---- ----- ---- ---- ---- ---- ---- ------------------- ---- ----
  **CHB-37**    CC                CC   CT   CC   CT   GG    GG   GG   CA   AA   GA   GG    GT   TT   CT   AA   CT   CA                  TT   GG
  **CHB-41**    CC                CC   TT   CC   CT   GG    TT   GT   CC   AT   GA   GG    TT   TT   TT   AA   TT   AA                  TT   GG
  **CHB-44**    CT                CC   CT   CT   TT   GG    GT   TT   AA   AA   GG   GG    TT   TT   CT   AA   TT   AA                  TT   GG
  **CHB-44**    CC                CC   TT   TT   TT   GG    TT   TT   CA   AA   GG   GG    TT   TT   TT   AA   TT   AA                  CT   GG
  **CHB-64**    CT                CT   CC   CT   CC   GG    GT   GT   CC   AA   GA   GG    GT   TT   TT   GA   CT   CA                  TT   GG
  **CHB-72**    CC                CT   CT   CC   CT   GG    GG   GG   CC   AA   GA   GG    TT   TT   CT   GA   CT   CA                  TT   GG
  **CHB-82**    CC                CC   TT   CC   CT   GG    GT   GT   CA   TT   GA   GG    TT   TT   CT   AA   CC   CC                  TT   GG
  **CHB-85**    CC                CT   TT   CT   CC   GG    GT   GT   AA   AA   GA   GG    TT   CT   CT   AA   CT   AA                  CT   GG
  **CHB-105**   CT                CT   CT   CT   CT   GG    GT   GT   CA   AT   GG   GG    TT   CT   CT   AA   TT   AA                  CT   GG
  **CHB-107**   CC                CC   CC   CT   CT   GG    TT   TT   CA   AA   GA   GG    TT   TT   CC   AA   TT   CC                  CT   GG
  **CHB-133**   CC                CC   TT   CT   CC   GG    TT   TT   CC   AA   GA   GG    TT   TT   TT   AA   TT   AA                  TT   GG
  **CHB-157**   CC                CC   CC   CT   CC   GG    GT   TT   CA   AA   GA   GA    TT   CC   TT   AA   TT   AA                  CT   GG

IL: interleukin, IFN: interferon, TNF: tumor necrosis factor, TGF: transforming growth factor, R: receptor, RA: receptor antagonist.

3. Selection of high-quality extension primers {#sec013}
----------------------------------------------

After multiplex PCR amplification of the quality control panel, the fluorescence signals of allele-specific extension primers in bead arrays were measured. In this study, allele-specific primers showing signals higher than 1000 MFI in the positive allele and lower than 500 MFI in the negative allele were determined as high quality. All primers presented in [Table 1](#pone.0118008.t001){ref-type="table"} were designed in the forward direction with melting temperatures within the range of 56°C to 60°C. None of the high-quality forward direction primers were improved in the reverse direction, length and for refractory extension. Reverse modification primers were designed in the 3′-to-5′ direction instead of the standard 5′-to-3′ direction. Length modification was performed by adding or removing nucleotide sequences at the 5′ end of forward or reverse primers. Refractory primers were modified by moving the 3′ end of the allele specific primer at 1 to 3 bases upstream of SNP region ([Fig. 2A](#pone.0118008.g002){ref-type="fig"}). The process of primer selection is presented in [Fig. 2B](#pone.0118008.g002){ref-type="fig"}.

![Principle of design and strategies for optimal selection on extension primers.\
(A) The design principle for the extension primers of IL-1RA (+11100) sequences. (B) The system for primer selection is divided into four major steps. In the forward direction step, nine of the forty primers were selected. The reverse direction was successful in fifteen of the thirty-one primers. The length modification step improved primer quality by adding or removing sequences at the 5′ end of each primer. In this step, nine of the sixteen primers were selected. In the last stage, the primers were improved by moving 1, 2 or 3 bp upstream of the SNP region at the allele-specific 3′ end. Three of the five primers were selected by the refractory system. Finally, 36 of the 40 primers were selected, but four primers (IL-10 (-1082) G, TGFβ1 (codon 10) G, T, IFN-γ (5644) T) were not selected. ^a^: Only the specificity of the primer was confirmed by QC panel because positive quality is not available.](pone.0118008.g002){#pone.0118008.g002}

The 9 forward direction extension primers (IL-1α (-889) C, IL-1α (-889) T, IL-1β (-511) T, IL-2 (166) T, IL-4 (-590) C, IL-4 (-590) T, IL-10 (-592) C, IL-10 (-592) A and TNF-α (-308) G) were selected as high quality among the first 40 forward direction primers designed. These primers were between 24 to 37 bases in length, with melting temperatures of 56.6 ± 0.7°C, and GC contents of 45.4 ± 11.5% ([Table 3](#pone.0118008.t003){ref-type="table"}). Nineteen of the 31 primers (IL-1β (-511) C, IL-2 (+166) G, IL-4 (-1098) T, IL-6 (-174) G, IL-6 (-174) C, IL-10 (-1082) G, IL-10 (-819) C, IL-10 (-819) T, IL-12 (-1188) C, IL-12 (-1188) A, TGF-β1 (codon 25) G, TGF-β1 (codon 25) C, TNF-α (-308) A, TNF-α (-238) G, TNF-α (-238) A, IFN-γ (5644) A, IFN-γ (5644) T, IL-4Rα (1902) C and IL-4Rα (1902) T) showed false positive results, and the remaining 12 primers showed false negative. The 31 primers of low quality were 18--37 bases in length, with melting temperatures of 57.2 ± 1.6°C, and GC contents of 51.4 ± 17.2%.

10.1371/journal.pone.0118008.t003

###### The final list of improved extension primers in the high-quality primer selection system.

![](pone.0118008.t003){#pone.0118008.t003g}

  Gene                         SNP Position   Direction   Length (bp)   Refractory   SNP   Primer Sequence                                 Tm (°C)   GC (%)
  ---------------------------- -------------- ----------- ------------- ------------ ----- ----------------------------------------------- --------- --------
  **Forward Direction**                                                                                                                              
  IL-1α                        -889           Forward                                C     GAAATTCTTTAATAATAGTAACCAGGCAACA**[C]{.ul}**     57        31
  IL-1α                        -889           Forward                                T     AGAAATTCTTTAATAATAGTAACCAGGCAACA**[T]{.ul}**    56        27
  IL-1β                        -511           Forward                                T     CCTGCAATTGACAGAGAGCTCC**[T]{.ul}**              57        52
  IL-2                         +166           Forward                                T     CACAGCTACAACTGGAGCATTTACT**[T]{.ul}**           56        42
  IL-4                         -590           Forward                                C     CACCTAAACTTGGGAGAACATTGT**[C]{.ul}**            56        44
  IL-4                         -590           Forward                                T     AAACACCTAAACTTGGGAGAACATTGT**[T]{.ul}**         56        36
  IL-10                        -592           Forward                                C     ATCCTGTGACCCCGCCTGT**[C]{.ul}**                 58        65
  IL-10                        -592           Forward                                A     ATCCTGTGACCCCGCCTGT**[A]{.ul}**                 56        60
  TNF-α                        -308           Forward                                G     GCAATAGGTTTTGAGGGGCATG**[G]{.ul}**              57        52
  **Reverse Direction**                                                                                                                              
  IL-1β                        +3962          Reverse                                C     TAAGCCTCGTTATCCCATGTGTC**[G]{.ul}**             57        50
  IL-1β                        +3962          Reverse                                T     TAAGCCTCGTTATCCCATGTGTC**[A]{.ul}**             56        46
  IL-2                         -330           Reverse                                G     ATACAAAAGTAACTCAGAAAATTTTCTTTGTC**[C]{.ul}**    56        27
  IL-2                         -330           Reverse                                T     GATACAAAAGTAACTCAGAAAATTTTCTTTGTC**[A]{.ul}**   56        26
  IL-4                         -1098          Reverse                                G     CTCAGCTAATTAGGAAAAAGAGCTAC**[C]{.ul}**          57        41
  IL-4                         -1098          Reverse                                T     CCTCAGCTAATTAGGAAAAAGAGCTAC**[A]{.ul}**         57        39
  IL-6                         -174           Reverse                                C     TGCAATGTGACGTCCTTTAGCAT**[G]{.ul}**             56        46
  IL-10                        -819           Reverse                                C     GAGCAAACTGAGGCACAGAGAT**[G]{.ul}**              57        52
  IL-10                        -819           Reverse                                T     TGAGCAAACTGAGGCACAGAGAT**[A]{.ul}**             56        46
  TNF-α                        -238           Reverse                                G     CTCCCCATCCTCCCTGCTC**[C]{.ul}**                 60        70
  TNF-α                        -238           Reverse                                A     CTCCCCATCCTCCCTGCTC**[T]{.ul}**                 58        65
  IL-1R                        +1970          Reverse                                C     CGCAGTGGTCGAGTCTGCA**[G]{.ul}**                 58        65
  IL-1R                        +1970          Reverse                                T     GCGCAGTGGTCGAGTCTGCA**[A]{.ul}**                58        62
  IL-4Rα                       1902           Reverse                                G     TCCACCGCATGTACAAACTCC**[C]{.ul}**               57        55
  IL-4Rα                       1902           Reverse                                A     CTCCACCGCATGTACAAACTCC**[T]{.ul}**              57        52
  **Length Modification**                                                                                                                            
  IL-1β                        -511           Forward     24                         C     TCCTGCAATTGACAGAGAGCTCC**[C]{.ul}**             59        54
  IL-2                         +166           Forward     23                         G     AGCTACAACTGGAGCATTTACT**[G]{.ul}**              53        43
  IL-6                         -174           Reverse     22                         G     CAATGTGACGTCCTTTAGCAT**[C]{.ul}**               53        45
  IL-10                        -1082          Forward     24                         A     ACACTACTAAGGCTTCTTTGGGA**[A]{.ul}**             56        42
  IL-12                        -1188          Reverse     24                         C     TGTTTCAATGAGCATTTAGCATC**[G]{.ul}**             52        38
  IL-12                        -1188          Reverse     23                         A     GTTTCAATGAGCATTTAGCATC**[T]{.ul}**              50        35
  TGF-β1                       codon 25       Forward     25                         G     GCTCACTGGTGCTGACGCCTGGCC**[G]{.ul}**            68        72
  TGF-β1                       codon 25       Forward     25                         C     GCTCACTGGTGCTGACGCCTGGCC**[C]{.ul}**            68        72
  TNF-α                        -308           Forward     22                         A     CAATAGGTTTTGAGGGGCATG**[A]{.ul}**               53        45
  **Refractory Mdification**                                                                                                                         
  IFN-γ                        5644           Reverse                   21(m-3)      A     GTGTGTGTGTGTGTGTG**[T]{.ul}**GAT                52        48
  IL-1RA                       +11100         Forward                   21(m-3)      C     TTCATCCGCTCAGACAG**[C]{.ul}**GGC                58        62
  IL-1RA                       +11100         Forward                   21(m-1)      T     GCCTTCATCCGCTCAGACAG**[T]{.ul}**G               59        59

IL: interleukin, IFN: interferon, TNF: tumor necrosis factor, TGF: transforming growth factor, R: receptor, RA: receptor antagonist

The SNP site in each primer is underlined.

Each extension primer used in this study has a unique "tag" sequence in the 5′ region

(An "anti-tag" that is a complementary "tag" immobilizes on the microspheres).

To improve the 31 failed forward primers, primers in the reverse direction were generated and tested. Fifteen reverse direction primers (IL-1β (+3962) C, IL-1β (+3962) T, IL-2 (-330) G, IL-2 (-330) T, IL-4 (-1098) G, IL-4 (-1098) T, IL-6 (-174) C, IL-10 (-819) C, IL-10 (-819) T, TNF-α (-238) G, TNF-α (-238) A, IL-1R (+1970) C, IL-1R (+1970) T, IL-4Rα (1902) G and IL-4Rα (1902) A) showed high quality.

These primers were between 20--34 bases in length, with melting temperatures of 57.1 ± 1.1°C, and GC contents of 49.5 ± 12.6% ([Table 3](#pone.0118008.t003){ref-type="table"}). The remaining 16 failed primers were 18--29 bases in length, with melting temperatures of 57.5 ± 1.2°C, and GC contents of 55.4 ± 13.4% (false positives; IL-1β (-511) C, IL-10 (-1082) G, IL-10 (-1082) A, IL-12 (-1188) C, IL-12 (-1188) A, TGF-β1 (codon 25) G, TGF-β1 (codon 25) C, TNF-α (-308) A, IFN-γ (5644) A and IFN-γ (5644) T, false negatives; IL-2 (+166) G, IL-6 (-174) G, TGF-β1 (codon 10) C, TGF-β1 (codon 10) T, IL-1RA (+11100) C and IL-1RA (+11100) T). Overall, the reverse direction primers of IL-1R (+1970) C and IL-2 (-330) G demonstrated improved specificity and sensitivity compared to forward primers, as shown in [Fig. 3A](#pone.0118008.g003){ref-type="fig"}.

![The optimal conditions for high-quality allele-specific primers.\
Strategy for improving the quality of the primers for IL-2 (-330) G, IL-1R (+1970) C, IL-1β (-511) C, TGF-β1 (codon 25) G and IL-1RA (+11100) T primer. (A) IL-1R (+1970) C and IL-2 (-330) G primers were improved by the reverse modification stage. (B) In the length modification stage, qualities of the IL-1β (-511) C and TGF β1 (codon 25) G primers were improved by adding or removing sequences at the 5′ end of each primer. (C) The IL-1RA (+11100) T primer failed in each of the forward, reverse direction and length modification stages. However, the IL-1RA (+11100) T primer was improved by moving 1 to 3 bp upstream of the SNP region at the allele-specific 3′ end. The sequences were used step by step for optimal extension primer selection. The high-quality primers showed signals higher than 1000 MFI in the positive allele and lower than 500 MFI in the negative allele. F: forward direction, R: reverse direction, L: length modification, Ref: refractory system. The SNP site in each primer is underlined. MFI: median fluorescence intensity.](pone.0118008.g003){#pone.0118008.g003}

The lengths of the 16 failed primers with forward or reverse direction were further modified from 18 bp to 30 bp. Nine primers (IL-1β (-511) C, IL-2 (166) G, IL-6 (-174) G, IL-10 (-1082) A, IL-12 (-1188) C, IL-12 (-1188) A, TGF-β1 (codon 25) G, TGF-β1 (codon 25) G and TNF-α (-308) A) were selected among a total of 68 primers tested (22--25 bases in length, with melting temperatures of 56.7 ± 6.5°C, and GC contents of 49.6 ± 13.0%). Overall, primers of IL-1β (-511) C and TGF-β1 (codon 25) showed improved positive signals by length modification as seen in [Fig. 3B](#pone.0118008.g003){ref-type="fig"}.

In the last assay, the locations of the mismatch SNP sites of these primers were modified to be at 1, 2 or 3 bp upstream of the 3′ end. Three primers (IFN-γ (5644) A, IL-1RA (+11100) C and IL-1RA (+11100) T were selected as high quality among a total 34 primers tested. Overall, the primer of IL-1RA (+11100) T showed improved positive and negative signals by refractory modification as in [Fig. 3C](#pone.0118008.g003){ref-type="fig"}.

Finally, four primers (IL-10 (-1082) G, TGF-β1 (codon 10) G, T, IFN-γ (5644) T) did not achieve acceptable quality despite modifications. IL-10 (-1082) G and TGF-β1 (codon 10) extension primers showed false negatives, while the IFN-γ (5644) T primer was showed a false positive result.

4. Concordance rate and cytokine SNP frequencies in Korean population {#sec014}
---------------------------------------------------------------------

After selection of the high-quality primers, seventeen SNPs of 12 cytokine genes were genotyped in 152 healthy Koreans by using the multiplex fluorescence bead array. The genotypes of the SNPs (ex; CC, CT and TT) as determined by the signal intensity ratio between the two corresponding bead types were divided into 3 districts. As a result, IL-1α (-889), IL-1β (-511), IL-1R (+1970), IL-1RA (+11100), IL-2 (+166), IL-2 (-330), IL-4 (-590), IL-4Rα (1902), IL-10 (-592), IL-10 (-819) and IL-12 (-1188) showed all 3 genotypes. IL-1β (+3962), IL-4 (-1098), IL-6 (-174), TNF-α (-238) and TNF-α (-308) were 1 heterozygote and 1 homozygote. TGF-β1 (codon 25) existed only in the homozygous state (GG) ([Fig. 4](#pone.0118008.g004){ref-type="fig"}).

![Scatter plot of fluorescence values detected by using allele-specific primer extension (ASPE) on a fluorescence bead array system.\
Raw fluorescence data are plotted for each cytokine SNP site. The red inverted open triangles represent homozygotes for allele A, the black filled diamonds are heterozygotes and the blue open squares are homozygotes for allele B. MFI: median fluorescent intensity.](pone.0118008.g004){#pone.0118008.g004}

In addition, the SNP frequency observed for each cytokine gene by multiplex fluorescence bead array was compared with data identified by sequencing-based typing (SBT). The specificity and sensitivity of the high-quality extension primers identified in a small-scale control panel were examined in 152 normal healthy Koreans; furthermore, the reproducibility and concordance rates were investigated. As a result, very weak positive signals of the six samples that had greater than 500 MFI were excluded from the genotyping results. The comparison results from the bead array method and SBT data in 146 normal healthy Koreans showed 100% concordance rate in IL-1α (-889), IL-1R (+1970), IL-1RA (+11100), IL-2 (+166), IL-4 (-1098), IL-4 (-590), IL-4Rα (1902), IL-6 (-174), IL-10 (-819), IL-10 (-592), IL-12 (-1188), TNF-α (-308), TNF-α (-238) and TGF-β1 (codon 25). These results showed that 14 of 17 SNPs were consistent with the sequencing data ([Table 4](#pone.0118008.t004){ref-type="table"}). The signal values of primers showing 100% concordance rates displayed positive values higher than the average at 2135 MFI, and negative values at less than 500 MFI ([Fig. 4](#pone.0118008.g004){ref-type="fig"}).

10.1371/journal.pone.0118008.t004

###### Concordance rate of the fluorescence bead array method vs. sequencing-based genotyping.

![](pone.0118008.t004){#pone.0118008.t004g}

           SNP        Concordance Rate   
  -------- ---------- ------------------ ------
  IL-1α    -889       146 / 146          100
  IL-1β    -511       143 / 146          97.9
           +3962      144 / 146          98.6
  IL-1R    +1970      146 / 146          100
  IL-1RA   +11100     146 / 146          100
  IL-2     +166       146 / 146          100
           -330       143 / 146          97.9
  IL-4     -1098      146 / 146          100
           -590       146 / 146          100
  IL-4Rα   1902       146 / 146          100
  IL-6     -174       146 / 146          100
  IL-10    -819       146 / 146          100
           -592       146 / 146          100
  IL-12    -1188      146 / 146          100
  TNF-α    -308       146 / 146          100
           -238       146 / 146          100
  TGF-β1   codon 25   146 / 146          100

IL: interleukin, IFN: interferon, TNF: tumor necrosis factor, TGF: transforming growth factor, R: receptor, RA: receptor antagonist.

On the other hand, three SNPs (IL-1β (-511), IL-1β (+3962), and IL-2 (-330)) were identified as error genotypes. However, two replicate experiments have managed to eliminated these results.

Finally, seventeen SNPs of 12 cytokine genes were genotyped and their frequencies determined in 146 healthy Koreans by the multiplexing system ([Fig. 5](#pone.0118008.g005){ref-type="fig"}). For each genotype frequency, an exact test of Hardy-Weinberg proportions was performed among the controls. All genotyped SNPs fit the Hardy-Weinberg equilibrium.

![Genotype frequencies of multiple cytokine SNPs in healthy Korean individuals (N = 146).\
IL: interleukin, IFN: interferon, TNF: tumor necrosis factor, TGF: transforming growth factor, R: receptor, RA: receptor antagonist.](pone.0118008.g005){#pone.0118008.g005}

Discussion {#sec015}
==========

Multiplex PCR is used for pathogen identification \[[@pone.0118008.ref024]\], high-throughput SNP genotyping \[[@pone.0118008.ref026]\], mutation analysis \[[@pone.0118008.ref027]\], gene deletion analysis \[[@pone.0118008.ref028],[@pone.0118008.ref029]\], quantitative analysis \[[@pone.0118008.ref030],[@pone.0118008.ref031]\], and RNA detection \[[@pone.0118008.ref032],[@pone.0118008.ref033]\]. The specificity and efficiency of amplification, as well as the process time for multiplex PCR have been enhanced by various improved primer designs and optimized reaction conditions. However, most multiplex PCR are limited to the amplification of 5 to 10 targets due to primer-primer interactions.

A single-tube 640-plex genotyping method has been reported for the detection of nucleic acid variations on microarrays \[[@pone.0118008.ref025]\]. According to this method, each specific primer was designed to cover one span between the forward and reverse primers. Among the 13 candidate cytokine genes, 12 cytokine SNPs were successfully defined with the selected allele-specific primers. However, the TGFβ1 gene (codons 10 and 25) was not amplified in the multiplex PCR due to the high GC content of the primer region. The TGFβ1-specific primer was eventually designed to 46 span between the forward and reverse primer, which were successful in the amplification without primer-primer interference. Compared to planar microarrays, suspension arrays benefits from ease of use, low cost, statistical superiority, faster hybridization kinetics, and more flexibility in array preparation. This bead array platform has been utilized in procedures such as allele-specific hybridization \[[@pone.0118008.ref019]\], single-base extension (SBE) \[[@pone.0118008.ref018],[@pone.0118008.ref034]\], allele-specific primer extension (ASPE) \[[@pone.0118008.ref026]\], and oligonucleotide ligation (OL) assay \[[@pone.0118008.ref035]\]. Although most manufactured high-density SNP arrays for GWAS generally employ the SBE method, we decided to use the allele-specific primer extension method instead to discriminate between the genotypes of multiple cytokine SNPs. The ASPE assay is in a one-color format and is specifically designed to allow the detection of all SNPs by using two identical extension primers differing only at the 3′ base. One of the extension primers is a perfect match for hybridization to allele A, while the other is the perfect match hybrid for allele B. The ability to detect all SNPs is useful for genotyping custom SNPs \[[@pone.0118008.ref036]\].

In this study, SNP genotypes were confirmed by scatter plot distribution using Korean control samples. Scatter plots depict median fluorescence intensities for alternate SNP alleles ([Fig. 4](#pone.0118008.g004){ref-type="fig"}). To select and improve the extension primers, modifications for the reverse direction, length and refractory were performed ([Fig. 2B](#pone.0118008.g002){ref-type="fig"}). Among a total of 204 extension primers tested, 24 primers were selected as high-quality primers in the forward direction step (forward and reverse), and then 12 primers were improved by adjusting the primer modifications (length and refractory). Interestingly, despite the fact that the lengths of 6 pairs of primers were shortened, they were showed a higher signal and increased specificity. These results indicate the significance of primer structures such as hairpin loops. The refractory modification used in this study may be similar to the ARMS technology \[[@pone.0118008.ref031]\]. However, we chose to move the 3′ end of the SNP region instead of changing the artificial mismatched base pair in the extension primer to improve specificity. As a result, two primers for IFN-γ (5644) A and IL-1RA (+11100) C were improved by moving the third base pair upstream of the SNP region at the allele-specific 3′-end. These results suggest that to improve the specificity of the allele-specific extension primer, the 3′-end of extension primers should be a mismatched site to be located at the second or third base pair rather than the first base pair behind the 3′ end. Also, to validate all the allele-specific extension primers, some genotypes (IL-1β (+3962) TT, IL-6 (-174) CC, TNF-α (-308) AA and TGF-β1 (codon 25) CC, CG) were confirmed to the reference sample from the International Histocompatibility Working Group (IHWG; <http://www.ihwg.org/reference/index.html>), because the presented genotypes were not detected in the Korean population (result data not shown). However, allele-specific extension primers for IL-4 (-1098) G and TNF-α (-238) A were confirmed only in the heterozygote because IL-4 (-1098) GG and TNF-α (-238) AA genotypes were not detected. In this system, we selected 36 high-quality extension primers of the 40 primers tested. SNP genotypes distinguished by SBT showed the same results with those of multiplex PCR coupled with a fluorescent bead array ([Table 4](#pone.0118008.t004){ref-type="table"}). The frequencies of multiple cytokine SNPs demonstrated in this study were consistent with previous studies also in the Korean population ([Fig. 5](#pone.0118008.g005){ref-type="fig"}) \[[@pone.0118008.ref037]\].

In conclusion, this study indicates that multiplex amplification can be successfully coupled with a fluorescent bead array detection method, and this combined platform provides a fast and high-throughput multiplex detection system for SNPs of multiple cytokine genes in a single tube format. Because cytokines act in complex regulatory networks, and gene---gene interactions are likely to be at the center of many disease associations, simultaneous testing of multiple SNPs are now being introduced to determine such relationships and this should ultimately allow a more accurate estimate of disease risk for individuals with particular cytokine gene profiles.
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